Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› End-Stage Renal Disease
Clinical trial register · United States · industry-sponsored

End-Stage Renal Disease Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9183 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 02 Nov 2026, 03:16 UTC
9183
Studies in scope
industry-sponsored, all four open statuses
4981
Recruiting now
open to new participants
2200
Lead sponsors
across recruiting studies
Top states
Florida 7 Massachusetts 6 California 5 New York 3 North Carolina 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

End-Stage Renal Disease trials in the USA

10 of 9183 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
NCT07793929End Stage Renal Disease, Renal Impairment, Obesity, Overweight
Kailera
Phase 1
32
Florida, Texas
2026-09-08
Not yet open
Xeno Holdings (US), LLC dba ChoironeX
Phase 1
4
New York
2026-09
Recruiting
Merit Medical Systems, Inc.
Observational
100
District of Columbia, Florida, North Carolina, Pennsylvania, Texas, Virginia
2025-07-28
Recruiting
Laminate Medical Technologies
Not applicable
300
California, Florida, Georgia, Louisiana, Massachusetts, Mississippi, Nevada, South Carolina
2025-01-13
By invitation
Xeltis Hemodialysis Access Graft (aXess) US Study
NCT06494631End Stage Renal Disease
Xeltis
Not applicable
140
Arizona, Florida, Massachusetts, Mississippi, North Carolina, Texas
2024-11-11
Recruiting
Sonavex, Inc.
Not applicable
304
Alabama, Arizona, Florida, Illinois, Kansas, Massachusetts, Michigan, New Jersey
2024-02-21
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
NCT06001827Chronic Kidney Diseases, End Stage Renal Disease, Arteriovenous Fistula, Hemodialysis Access Failure
VenoStent
Not applicable
600
Arizona, California, Florida, Indiana, Kentucky, Massachusetts, Minnesota, Missouri
2024-01-03
Recruiting
LifeNet Health
Observational
100
Alabama, California, Virginia
2023-06-06
Recruiting
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
NCT04580420Primary Hyperoxaluria Type 1, End Stage Renal Disease
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 2
28
California, Massachusetts, Minnesota, New York
2021-04-15
Recruiting
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT04634916Kidney Disease, End-Stage, End-stage Renal Disease, Arteriovenous Fistula
C. R. Bard
Not applicable
220
California, Florida, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Tennessee
2021-03-26
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 3 November 2026. https://priyalifescience.com/clinical-trials-usa/condition/end-stage-renal-disease

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,183 studies in total at the last sync on 02 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition End-Stage Renal Disease.

How many End-Stage Renal Disease trials are recruiting in the US?

8 of the 10 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (End-Stage Renal Disease), 10 studies
PhaseStudiesRecruitingShare
Not applicable5450%
Observational2220%
Phase 12120%
Phase 21110%

Most active sponsors

Lead sponsors with the most studies (End-Stage Renal Disease)
Lead sponsorStudiesRecruiting
C. R. Bard11
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company11
Kailera11
Laminate Medical Technologies11
LifeNet Health11
Merit Medical Systems, Inc.11
Sonavex, Inc.11
VenoStent11
Xeltis10
Xeno Holdings (US), LLC dba ChoironeX10

Top states

Top states (End-Stage Renal Disease), by number of studies with a site there
StateStudies
Florida7
Massachusetts6
California5
Arizona3
New York3
North Carolina3
Texas3
Alabama2
Minnesota2
Mississippi2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.